Core Viewpoint - A securities fraud class action lawsuit has been filed against monday.com Ltd. for allegedly making materially false and misleading statements regarding its business operations and growth prospects during the specified class period [1][2]. Company Overview - monday.com Ltd. is facing legal action due to claims that it misrepresented its customer growth and the effectiveness of its AI investments, which are critical for long-term growth [2][3]. - The lawsuit covers the period from September 17, 2025, to February 6, 2026, with a deadline for investors to seek lead plaintiff status set for May 11, 2026 [1][3]. Financial Impact - On February 9, 2026, monday.com announced a significant revision of its revenue outlook, rescinding its $1.8 billion revenue target for 2027 and indicating a deceleration in top-line growth for 2026. This announcement led to a stock price drop of $20.37, or 20.8%, closing at $77.63 per share [3]. Legal Proceedings - The lawsuit is filed in the United States District Court for the Southern District of New York, under the case caption Potter v. monday.com Ltd., Case No. 26-cv-01956 [1]. - Investors who have lost money on their investments in monday.com are encouraged to contact Kessler Topaz Meltzer & Check, LLP for potential recovery options [2][3].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of ImmunityBio, Inc. securities, alleging securities fraud during the Class Period from January 19, 2026, to March 24, 2026 [1]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and misleading statements regarding Anktiva's capabilities and ImmunityBio's business operations, leading to investor damages when the truth was revealed [5]. - Investors who purchased ImmunityBio securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - To join the class action, investors can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must move the Court by May 26, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Gemini Space Station, Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the period from September 12, 2025, to February 17, 2026 [2][4][7]. Group 1: Lawsuit Details - The lawsuit is filed in the United States District Court for the Southern District of New York, captioned Methvin v. Gemini Space Station, Inc., et al, Case No. 1:26-cv-02261 [2][7]. - Investors who purchased Gemini Class A common stock or securities during the specified period have until May 18, 2026, to file for lead plaintiff status [2][7]. - The complaint alleges that Gemini overstated the viability of its core business as a crypto platform and its commitment to expanding international operations, leading to an inflated perception of its post-IPO financial prospects [4]. Group 2: Stock Performance and Corporate Changes - On February 5, 2026, Gemini announced a corporate pivot to "Gemini 2.0," which included a 25% workforce reduction and exiting several international markets, resulting in an 8.72% drop in its Class A common stock price to $6.70 per share [5]. - Following the announcement of the departure of key executives and a 40% increase in operating expenses, the stock price fell further by 12.9% to close at $6.585 per share on February 17, 2026 [6]. - At the time the complaint was filed, Gemini's Class A common stock was trading at $5.96 per share, reflecting a 78.7% decline from its IPO price of $28.00 per share [8].

Core Viewpoint - Alight, Inc. shareholders who experienced financial losses have the opportunity to lead a securities fraud class action lawsuit against the company due to alleged misleading statements regarding its business performance and operations [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that from November 12, 2024, to February 18, 2026, Alight failed to disclose that its reports of growth and cost-cutting measures were not reflective of reality [3]. - It is claimed that the company's sales team was not adequately prepared to meet management's expectations, leading to materially misleading statements about the company's business and prospects [3]. Group 2: Participation Information - Investors who suffered losses related to Alight are encouraged to participate in the ongoing securities fraud lawsuit, with a lead plaintiff deadline set for May 15, 2026 [2][4]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to learn about their rights regarding the lawsuit [4][5].

Core Viewpoint - Investors in Power Solutions International, Inc. (PSIX) who have incurred losses have the opportunity to lead a securities fraud class action lawsuit against the company [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that from May 8, 2025, to March 2, 2026, the company failed to disclose critical information, including the overstatement of its ability to capture sales demand for its power systems solutions, particularly in the data center market [3]. - It is claimed that the company understated the impact of enhancements to its manufacturing capacity to meet demand in the data center market, including expected costs and related inefficiencies [3]. - As a result of these issues, the positive statements made by the company regarding its business, operations, and prospects were materially misleading and lacked a reasonable basis [3].

Core Viewpoint - Super Micro Computer is facing a class-action lawsuit for allegedly misleading investors regarding its exposure to China and compliance risks related to the sale of export-controlled Nvidia chips [1][2]. Group 1: Lawsuit Details - Shareholders claim that Super Micro overstated its growth prospects by not disclosing that a significant portion of its server sales were linked to China, which may violate U.S. export controls [2]. - The lawsuit, filed in federal court in San Francisco, alleges that the company had material weaknesses in its compliance systems while presenting a stronger business outlook to investors [3]. Group 2: Criminal Charges and Stock Impact - The legal action follows criminal charges against co-founder Yih-Shyan Liaw and two others for allegedly orchestrating sales of servers containing Nvidia chips to China through a Southeast Asian intermediary [4]. - Super Micro's stock dropped 33% on March 20 after the charges were disclosed, resulting in a loss of approximately $6.1 billion in market value [4]. - Prosecutors allege that the scheme involved about $2.5 billion worth of servers sold in 2024 and 2025 [4]. Group 3: Company Response - Super Micro has stated that it is cooperating with authorities, and neither the company nor Nvidia has been criminally charged; Nvidia is not named in the civil suit [5]. - The lawsuit also names CEO Charles Liang and CFO David Weigand as defendants [5].

Core Viewpoint - A class action lawsuit has been filed against Lufax Holding Ltd. for securities fraud, affecting investors who purchased shares between April 7, 2023, and January 26, 2025, with a deadline for lead plaintiff motions set for May 20, 2026 [1]. Group 1: Lawsuit Details - The lawsuit alleges that Lufax made materially false and misleading statements and failed to disclose adverse facts about its business and financial condition during the class period [4]. - Lufax's stock price dropped by $0.40, or 13.8%, to close at $2.49 per share on January 27, 2025, following the announcement of concerns from its auditor, PricewaterhouseCoopers (PwC) [3]. - On February 17, 2025, Lufax confirmed that its 2022 and 2023 financial reports were unreliable, revealing material net profit declines from previously issued reports [4]. Group 2: Financial Disclosures - The lawsuit highlights that Lufax lacked adequate internal controls and that certain financial results were materially misstated, leading to misleading positive statements about the company's operations and prospects [4]. - The 2024 Annual Report provided restated net profit figures, indicating significant discrepancies from earlier reports [4].

Core Viewpoint - A securities fraud class action lawsuit has been filed against NuScale Power Corporation for misleading statements regarding its commercialization strategy and financial performance during the specified class period [2][4][7]. Group 1: Lawsuit Details - The lawsuit is filed on behalf of investors who purchased NuScale Class A common stock between May 13, 2025, and November 6, 2025 [2][7]. - The case is titled Truedson v. NuScale Power Corporation, et al, and is being heard in the United States District Court for the District of Oregon [2]. - Investors have until April 20, 2026, to file for lead plaintiff status [2][8]. Group 2: Allegations - The complaint alleges that NuScale made false and misleading statements about ENTRA1 Energy LLC's capabilities in nuclear power generation [4]. - It is claimed that NuScale's reliance on ENTRA1 for its commercialization strategy exposed the company to undisclosed risks, including potential failures and regulatory challenges [4]. - The lawsuit highlights that ENTRA1 had no significant experience in building or operating nuclear energy projects, which was misrepresented by NuScale [4]. Group 3: Financial Impact - On November 6, 2025, NuScale reported a dramatic increase in general and administrative expenses, rising over 3,000% to $519 million, primarily due to a $495 million payment to ENTRA1 [5]. - This financial disclosure led to a significant quarterly net loss of $532 million, compared to a loss of $46 million in the previous year [5]. - Following this announcement, NuScale's stock price dropped by $5.45 per share, approximately 14.4%, closing at $32.46 on November 6, 2025 [5].

Core Viewpoint - A securities fraud class action lawsuit has been filed against Soleno Therapeutics, Inc. for allegedly making false statements and failing to disclose material adverse facts regarding its Phase 3 clinical trial for its product DCCR, which is intended for treating hyperphagia in individuals with Prader-Willi syndrome [2][5][6]. Company Overview - Soleno Therapeutics, Inc. is a pharmaceutical company based in Redwood City, California, focused on developing therapies for rare diseases. Its only commercial product at the time of the lawsuit was diazoxide choline extended-release tablets (DCCR) [4]. Lawsuit Details - The lawsuit was filed on behalf of investors who purchased Soleno common stock between March 26, 2025, and November 4, 2025, and is pending in the United States District Court for the Northern District of California [2][6]. - Investors have until May 5, 2026, to file for lead plaintiff status [2][8]. Allegations Against Soleno - The complaint alleges that Soleno's executives made materially false and misleading statements regarding the safety and commercial viability of DCCR, including downplaying safety concerns related to excess fluid retention in clinical trial participants [5]. - It is claimed that these misrepresentations led to a lower likelihood of successful commercial adoption and increased risks of adverse events post-launch [5]. Stock Performance - Following the release of financial results on November 4, 2025, and a report by Scorpion Capital that raised concerns about DCCR, Soleno's stock price dropped over 26% due to a decline in patient start forms and increased discontinuations [6][7].

Core Viewpoint - The Super Micro Computer, Inc. is facing a class action lawsuit due to allegations of misleading statements and violations of U.S. export control laws related to significant sales to Chinese companies [4][5]. Group 1: Lawsuit Details - The class action lawsuit, titled Bhuva v. Super Micro Computer, Inc., aims to represent investors who purchased Super Micro securities and alleges violations of the Securities Exchange Act of 1934 [1]. - The lawsuit claims that Super Micro's sales to Chinese companies violated U.S. export control laws and that there were material weaknesses in the company's compliance controls [4]. - The U.S. Department of Justice announced an indictment against three individuals associated with Super Micro for diverting servers with U.S. AI technology to China, allegedly generating approximately $2.5 billion in sales from 2024 to 2025 [5]. Group 2: Financial Impact - Following the DOJ announcement regarding the indictment, Super Micro's stock price fell by more than 33% [5]. - The lawsuit allows any investor who suffered substantial losses during the class period to seek appointment as lead plaintiff, which is crucial for directing the class action [6]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is leading the class action lawsuit and is recognized as a top law firm in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [7].